Viome Life Sciences
The company will use the funds to launch its diagnostics division and expand its offerings under the helm of its new chief operating officer.
The Washington-based company will combine Naring Health, DiscernDx and Foodome's resources with its own offerings to develop personalized nutrition options.
The life sciences company's Gut Intelligence Test will be available in 200 CVS locations and through the drugstore chain online.
The multinational pharma company will now be able to access Tempus' de-identified patient data.
Genomic testing company Variantyx raised $20 million in debt financing, and mental health provider Mindful Care scooped up $7 million.
The clinical trial results will be used to expand Viome’s mRNA platform, which in May received FDA breakthrough device designation for identifying early signs of oral and throat cancers.